Industrial Pharmacy Management
Pharmacy benefit manager (PBM) is a third-party administrator of prescription drug programs. PBMs are primarily responsible for developing and maintaining the formulary, contracting with pharmacies, negotiating discounts and rebates with drug manufacturers, and processing and paying prescription drug claims. PBMs also offer programs that provide value and flexibility to participants to help control prescription costs. Some of these areas include information about tablet splitting, lower-cost therapeutic alternatives, and tiered trial of specific medications in a therapeutic class, evaluating clinical programs for large populations, medication therapy management programs, and mail order service.
Specialty drugs are prescribed to treat complex conditions such as cancer, HIV and inflammatory diseases. While these drugs fulfil the promise of modern medicine by enriching and often extending a patient’s quality of life Specialty pharmaceutical spending is on the rise and is expected to increase from approximately $55 billion in 2005 to $1.7 trillion in 2030, according to the Pharmaceutical Care Management Association Specialty drugs are frequently administered by medical professionals at higher-cost treatment sites such as hospitals, infusion centres and physician offices. These drugs also require special handling, administration, patient education, and clinical support -- all of which further drive up their cost Pharmaceutical management teaches how to provide the correct drugs in the correct amount to individuals.
Pharmacy benefit manager (PBM) is a third-party administrator of prescription drug programs. PBMs are primarily responsible for developing and maintaining the formulary, contracting with pharmacies, negotiating discounts and rebates with drug manufacturers, and processing and paying prescription drug claims.
- pharmacy benefit management industry
- drug development and industrial pharmacy
- specialty pharmacy industry
- Pharmaceutical Management
Related Conference of Industrial Pharmacy Management
International Conference and Exhibition on Drug Safety & Pharmacovigilance
Industrial Pharmacy Management Conference Speakers
Recommended Sessions
- Clinical Studies
- Drug Design and Marketing
- Drug Development Stages
- Drug discovery and drug development
- Functions of Regulatory Bodies
- Good manufacturing practices
- Healthcare pharmacy
- Industrial Pharmacist Experts
- Industrial Pharmacy Management
- Market Surveillance of Industrial Pharmacy
- Pharmacy from Natural products
- Veternary Pharmaceuticals
- Waste management of industrial pharmacy
Related Journals
- Journal of Developing Drugs
- Drug Designing
- Clinical and Experimental Pharmacology
- Journal of Drug Metabolism & Toxicology
- Journal of Pharmaceutical Care & Health Systems More
Are you interested in
- BCS & IVIVC Based Biowaivers - Asian Biosimilars 2018 (Japan)
- Bioequivalence Assessment - Asian Biosimilars 2018 (Japan)
- Biosimilar Companies and Market Analysis - Asian Biosimilars 2018 (Japan)
- Biosimilar Market and Cost Analysis - Asian Biosimilars 2018 (Japan)
- Biosimilars Analytical Strategies - Asian Biosimilars 2018 (Japan)
- Biosimilars Research Pipeline - Asian Biosimilars 2018 (Japan)
- Brexit Effect on Biosimilars - Asian Biosimilars 2018 (Japan)
- Challenges in Developing Biosimilars - Asian Biosimilars 2018 (Japan)
- Clinical Studies on Biosimilars - Asian Biosimilars 2018 (Japan)
- Emerging Biosimilars in Therapeutics - Asian Biosimilars 2018 (Japan)
- Emerging Trends in Biosimilars - Asian Biosimilars 2018 (Japan)
- Entrepreneurs Investment Meet - Asian Biosimilars 2018 (Japan)
- Globalization of Biosimilars - Asian Biosimilars 2018 (Japan)
- Intellectual Property Rights - Asian Biosimilars 2018 (Japan)
- Latest Biosimilars in Asian Scenario - Asian Biosimilars 2018 (Japan)
- Legal Issues and BPCI Act - Asian Biosimilars 2018 (Japan)
- Pharmacovigilance of Biosimilars - Asian Biosimilars 2018 (Japan)
- Regulatory Approach for Biosimilars - Asian Biosimilars 2018 (Japan)